Shares of Vislink Technologies fell after the company posted a wider third-quarter loss and lower-than-expected revenue. The stock fell 32% to $4.45 in afternoon trading Thursday. For the year, shares ...

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Electrovaya secured a direct loan totaling $50.8 million from the Export-Import Bank of the U.S. under the bank's initiative to spur domestic manufacturing.

Shares of Medicus Pharma tumbled 39%, to $2.50, on the company's first day of trading Thursday. The biotechnology and life-sciences pharmaceutical company on Wednesday said it would sell 970,000 units ...

Shares of Pulmatrix hit a 52-week high on the Nasdaq, more than doubling their opening price before giving back gains, following news of a planned merger with privately held biopharmaceutical company ...

Shares of Dillard's climbed after the department-store operator said it is focusing on its gross margin and expenses as it logged lower sales in its fiscal third quarter. The stock was up 11%, to $432 ...

Worries that EV tax credits may go away under the Trump administration hit a fever pitch on Thursday, dragging down the ...

Credit spreads on investment-grade U.S. corporate bonds have been falling back to more than 20-year lows as recession fears fade. The ICE BofA US Corporate Index spread was last pegged at a spread of ...

PDS Biotechnology shares declined after it issued an update about a cancer study with a combination of Versamune HPV and pembrolizumab and reported quarterly results. The stock was down 18%, to $2.25, ...

American depositary receipts of Geely Automobile subsidiary Zeekr Intelligent Technology fell after the Chinese electric-vehicle manufacturer said it plans to acquire a 50% stake in Lynk & Co from its ...

The U.S. dollar remains an unabashed beneficiary of Donald Trump’s presidential election win — and it’s relentless rise is ...